These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21148812)

  • 41. [Osteonecroses of the bilateral tali during maintenance therapy in a child with acute lymphoblastic leukemia].
    Nozaki H; Matsubara K; Mori S
    Rinsho Ketsueki; 2006 Feb; 47(2):106-10. PubMed ID: 16529012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
    Bürger B; Beier R; Zimmermann M; Beck JD; Reiter A; Schrappe M
    Pediatr Blood Cancer; 2005 Mar; 44(3):220-5. PubMed ID: 15514916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.
    Sherief LM; Beshir M; Raafat N; Abdelkhalek ER; Mokhtar WA; Elgerby KM; Soliman BK; Salah HE; Mokhtar GA; Kamal NM; ELsayed H; Zakaria M
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1700. PubMed ID: 34042331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
    Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
    Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole-joint magnetic resonance imaging to assess osteonecrosis in pediatric patients with acute lymphoblastic lymphoma.
    Inaba H; Varechtchouk O; Neel MD; Ehrhardt MJ; Metzger ML; Karol SE; Ness KK; Ribeiro RC; Pui CH; Relling MV; Sandlund JT; Kaste SC
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28336. PubMed ID: 32472969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osteonecrosis in children with acute lymphoblastic leukemia: a 10-year study from northern Greece.
    Tragiannidis A; Athanassiadou F; Papageorgiou T; Petsatodis G; Sidi V; Koliouskas D
    Pediatr Blood Cancer; 2007 Oct; 49(5):764. PubMed ID: 17216599
    [No Abstract]   [Full Text] [Related]  

  • 47. Unique MRI findings as an early predictor of osteonecrosis in pediatric acute lymphoblastic leukemia.
    Sansgiri RK; Neel MD; Soto-Fourier M; Kaste SC
    AJR Am J Roentgenol; 2012 May; 198(5):W432-9. PubMed ID: 22528924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice.
    Finch ER; Payton MA; Jenkins DA; Cai X; Li L; Karol SE; Relling MV; Janke LJ
    Haematologica; 2021 Aug; 106(8):2095-2101. PubMed ID: 32675219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia.
    Yang L; Panetta JC; Cai X; Yang W; Pei D; Cheng C; Kornegay N; Pui CH; Relling MV
    J Clin Oncol; 2008 Apr; 26(12):1932-9. PubMed ID: 18421047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone.
    Waber DP; Carpentieri SC; Klar N; Silverman LB; Schwenn M; Hurwitz CA; Mullenix PJ; Tarbell NJ; Sallan SE
    J Pediatr Hematol Oncol; 2000; 22(3):206-13. PubMed ID: 10864051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of the Relationship Between
    Erdem M; Tüfekçi Ö; Kızıldağ S; Yılmaz Ş; Kızmazoğlu D; Eroğlu Filibeli B; Ören H
    Turk J Haematol; 2019 Feb; 36(1):12-18. PubMed ID: 30251958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).
    Padhye B; Dalla-Pozza L; Little D; Munns C
    Cancer Med; 2016 May; 5(5):960-7. PubMed ID: 26792372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [MRI of aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukemia].
    Engelbrecht V; Scherer A; Bruder M; Körholz D; Mödder U
    Rofo; 2000 Apr; 172(4):336-41. PubMed ID: 10961217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The incidence of symptomatic osteonecrosis after allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia - controversy on dexamethasone as a risk factor.
    Tanoshima R; Carleton BC
    Br J Haematol; 2019 Jun; 185(5):958-959. PubMed ID: 30408145
    [No Abstract]   [Full Text] [Related]  

  • 55. MR imaging of osteonecrosis of the knee in children with acute lymphocytic leukemia.
    Karimova EJ; Kaste SC
    Pediatr Radiol; 2007 Nov; 37(11):1140-6. PubMed ID: 17768614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Team approach: Management of osteonecrosis in children with acute lymphoblastic leukemia.
    Jones LC; Kaste SC; Karol SE; DeFeo B; Kim HKW; Neel MD; Levin AS
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28509. PubMed ID: 32860663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ALL and osteonecrosis.
    Gaynon PS
    Blood; 2015 Oct; 126(15):1734-5. PubMed ID: 26450951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia.
    Elmantaser M; Stewart G; Young D; Duncan R; Gibson B; Ahmed SF
    Arch Dis Child; 2010 Oct; 95(10):805-9. PubMed ID: 20576660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
    Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
    Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.